GLAXOSMITHKLINE PHARMACEUTICALS
Back to Balance Sheet
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹1,779 Cr | ₹1,905 Cr | ₹1,525 Cr | ₹1,326 Cr | ₹1,698 Cr |
What is the latest Total Current Liabilities ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹1,779 Cr |
| Mar2025 | ₹1,905 Cr |
| Mar2024 | ₹1,525 Cr |
| Mar2023 | ₹1,326 Cr |
| Mar2022 | ₹1,698 Cr |
How is Total Current Liabilities of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,779 Cr | -6.62 | |
| Mar2025 | ₹1,905 Cr | 24.93 | |
| Mar2024 | ₹1,525 Cr | 14.97 | |
| Mar2023 | ₹1,326 Cr | -21.91 | |
| Mar2022 | ₹1,698 Cr | - | |
Compare Total Current Liabilities of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹45,734.6 Cr | 4% | 10% | 1.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,675.0 Cr | -3% | -2.6% | 21.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,516.0 Cr | -0.5% | 17% | 43.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,190.0 Cr | 0.6% | 2.7% | 35.5% | Stock Analytics | |
| CIPLA | ₹115,523.0 Cr | -2.2% | 0.8% | -2.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,493.4 Cr | -1.1% | -1.6% | -0.8% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | 4% |
10% |
1.5% |
| SENSEX | -1% |
0.7% |
-3.6% |
You may also like the below Video Courses